Lasciate un messaggio
Ti richiameremo presto!
Il tuo messaggio deve contenere da 20 a 3000 caratteri!
Si prega di controllare la tua email!
Ulteriori informazioni facilitano una migliore comunicazione.
Inviato con successo!
Ti richiameremo presto!
Lasciate un messaggio
Ti richiameremo presto!
Il tuo messaggio deve contenere da 20 a 3000 caratteri!
Si prega di controllare la tua email!
—— PHARMA DI SIMPOR
—— Nasir
—— IATEC, Argentina
—— Mohammed Saad
HEPA filters achieve ≥99.97% efficiency for particles ≥0.3μm, while ULPA filters offer superior performance with ≥99.9995% efficiency for particles ≥0.1μm. This makes ULPA ideal for ISO Class 3 environments (e.g., semiconductor fabrication), whereas HEPA suffices for ISO Class 5 zones (e.g., pharmaceutical cleanrooms). ULPA's enhanced capture of submicron particles (e.g., viruses like SARS-CoV-2 at 60–140nm) provides critical protection in high-risk areas like BSL-4 labs.
HEPA filters typically exhibit lower initial resistance (150–250Pa) compared to ULPA (100–250Pa), reducing energy consumption in HVAC systems. However, ULPA's extended lifespan (up to 24 months vs. HEPA's 12–18 months) offsets higher upfront costs. Studies show ULPA's mini-pleated designs can lower pressure drop by 10Pa, saving ~113kWh annually per filter at 3,400m³/h airflow.
HEPA filters are standard in ICU and surgery rooms (H13–H14 grades), while ULPA is mandatory for BSL-4 labs and semiconductor "cleanroom islands." Case studies reveal dual-stage HEPA (H13+H14) achieves ISO Class 5 in hospitals, whereas ULPA+Ag⁺ filters (e.g., JV-BioFilter) are deployed in Wuhan P4 Lab for viral containment. Modular cleanrooms often combine both: HEPA for general zones and ULPA for critical workflows.

